USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
Pramipexole Dihydrochloride Extended-Release Tablets

BRIEFING

Pramipexole Dihydrochloride Extended-Release Tablets. Because there is no existing USP monograph for this drug product, a new monograph based on validated methods of analysis is proposed.

  1. The liquid chromatographic procedure in the Assay was validated using the Inertsil ODS-3V brand of column with L1 packing. The typical retention time for pramipexole is about 5 min.

  2. The liquid chromatographic analytical procedure in Dissolution Test 1 was validated using the Inertsil ODS-3V brand of column with L1 packing. The typical retention time for pramipexole is about 4 min.

  3. The liquid chromatographic analytical procedure in Dissolution Test 2 was validated using the ACE C18 brand of column with L1 packing. The typical retention time for pramipexole is about 6 min.

  4. The liquid chromatographic procedure in the Organic Impurities test was validated using the Inertsil ODS-3V brand of column with L1 packing. The typical retention time for pramipexole is about 38 min.

 (SM4: R. Nguyen)

 Correspondence Number—C196168; C305588

USP REFERENCE STANDARDS FOR PURCHASE

USP Pramipexole Dihydrochloride Monohydrate RS
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!